4//SEC Filing
Piper Brian 4
Accession 0001144204-17-043513
CIK 0001138776other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:17 PM ET
Size
5.7 KB
Accession
0001144204-17-043513
Insider Transaction Report
Form 4
Piper Brian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase)
2017-08-11+380,000→ 380,000 totalExercise: $1.32Exp: 2027-08-11→ Common Stock (380,000 underlying)
Footnotes (1)
- [F1]The option award vests and becomes exercisable as follows (rounded up to the nearest whole share of common stock): one-third on August 11, 2018, then in 24 equal monthly installments on the 11th day of each subsequent calendar month, subject to the reporting person's continued service with the issuer.
Documents
Issuer
Aevi Genomic Medicine, Inc.
CIK 0001138776
Entity typeother
Related Parties
1- filerCIK 0001665924
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:17 PM ET
- Size
- 5.7 KB